USFDA accepts sBLA of TIVDAK for priority review for patients with metastatic cervical cancer
Submission based on positive results from global phase 3 study demonstrating overall survival benefit of TIVDAK over chemotherapy
Submission based on positive results from global phase 3 study demonstrating overall survival benefit of TIVDAK over chemotherapy
The primary goal of this joint venture is to develop and commercialise novel cell therapy products for major unmet medical needs in the United States, Japan, and EU regions
The congress aims at emphasizing on the most recent trends, advancements in the field of Obstetrics & Gynaecology
Medway setup a state-of-the-art Heart Institute in Chennai
Sirius JV will be owned 51% by Sirius and 49% by Adani
Karkinos Healthcare has demonstrated exceptional dedication to privacy, setting a commendable example for businesses navigating the complexities of the digital landscape
This combination aims to offer an effective tool to manage symptoms of nausea and vomiting during pregnancy
MedTech Mitra is a platform that will help the young talents of the country by holding their hands and giving them final shape to their research, knowledge and logic
If approved, patritumab deruxtecan would be a first-in-class HER3 directed DXd antibody drug conjugate for these patients
Anticipates approx. US$8 billion in revenues for Comirnaty and Paxlovid
Subscribe To Our Newsletter & Stay Updated